PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 15 filers reported holding PURPLE BIOTECH LTD in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,329 | -9.4% | 14,562 | +6.2% | 0.00% | 0.0% |
Q2 2023 | $19,137 | -18.2% | 13,718 | +5.0% | 0.00% | 0.0% |
Q1 2023 | $23,392 | +29.7% | 13,068 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $18,034 | -30.6% | 13,068 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $26,000 | -99.9% | 13,068 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $31,232,000 | +72532.6% | 13,068 | +18.1% | 0.00% | -33.3% |
Q1 2022 | $43,000 | 0.0% | 11,068 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $43,000 | -6.5% | 11,068 | +9.9% | 0.00% | 0.0% |
Q3 2021 | $46,000 | – | 10,068 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 50,590 | $247,000 | 0.04% |
Point72 Asset Management, L.P. | 525,000 | $2,562,000 | 0.01% |
Belvedere Trading LLC | 31,000 | $150,000 | 0.01% |
CONDOR CAPITAL MANAGEMENT | 21,000 | $102,000 | 0.01% |
WASHINGTON TRUST BANK | 16,454 | $80,000 | 0.01% |
Belvedere Trading LLC | 5,600 | $27,000 | 0.00% |
Orbimed Advisors | 17,712 | $86,000 | 0.00% |
HAP Trading, LLC | 20,600 | $21,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 42,281 | $206,000 | 0.00% |